Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab and PDT in Persistent PCV
NCT02864472Phase 4Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2016
- Primary completion
- Jun 2018
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 4 trial of ranibizumab in polypoidal choroidal vasculopathy (PCV), sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
ranibizumab
03
Conditions
polypoidal choroidal vasculopathy (PCV)
Beyond the preview
Go deeper on NCT02864472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02864472.